{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:35:41Z","timestamp":1787654141444,"version":"build-2736575974"},"reference-count":80,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:00:00Z","timestamp":1774137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.dld.2026.03.009","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T18:44:04Z","timestamp":1776019444000},"page":"871-878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Thrombosis and anticoagulation in patients with Cirrhosis. An overview"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4460-7643","authenticated-orcid":false,"given":"Dominique-Charles","family":"Valla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2026.03.009_bib0001","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/HEP.0000000000000756","article-title":"Reappraisal of the conventional hemostasis tests as predictors of perioperative bleeding in the era of rebalanced hemostasis in cirrhosis","volume":"82","author":"Tripodi","year":"2025","journal-title":"Hepatology"},{"issue":"Suppl","key":"10.1016\/j.dld.2026.03.009_bib0002","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.3350\/cmh.2024.0928","article-title":"Prediction and prevention of post-procedural bleedings in patients with cirrhosis","volume":"31","author":"Riescher-Tuczkiewicz","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.dld.2026.03.009_bib0003","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/HEP.0000000000000349","article-title":"The evolving knowledge on primary hemostasis in patients with cirrhosis: a comprehensive review","volume":"79","author":"Zanetto","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2026.03.009_bib0004","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.thromres.2024.03.017","article-title":"Comprehensive investigation of platelet function in patients with cirrhosis","volume":"237","author":"Leechi","year":"2024","journal-title":"Thromb Res"},{"key":"10.1016\/j.dld.2026.03.009_bib0005","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/jth.15239","article-title":"The concept of rebalanced hemostasis in patients with liver disease: communication from the ISTH SSC working group on hemostatic management of patients with liver disease","volume":"19","author":"Lisman","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.dld.2026.03.009_bib0006","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.jhep.2021.11.004","article-title":"Intagliata NM. Haemostatic alterations and management of haemostasis in patients with cirrhosis","volume":"76","author":"Lisman","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2026.03.009_bib0007","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.20569","article-title":"Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests","volume":"41","author":"Tripodi","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2026.03.009_bib0008","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/hep.21266","article-title":"Thrombin generation in patients with cirrhosis: the role of platelets","volume":"44","author":"Tripodi","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2026.03.009_bib0009","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jhep.2013.03.036","article-title":"Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis","volume":"59","author":"Tripodi","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2026.03.009_bib0010","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1111\/jth.15888","article-title":"Predicting bleeding after liver biopsy using comprehensive clinical and laboratory investigations: a prospective analysis of 302 procedures","volume":"20","author":"Bissonnette","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.dld.2026.03.009_bib0011","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jhep.2024.12.008","article-title":"Impaired whole blood thrombin generation is associated with procedure-related bleeding in acutely decompensated cirrhosis","volume":"82","author":"Zanetto","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2026.03.009_bib0012","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2021.12.038","article-title":"Factor VIII\/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD","volume":"76","author":"Scheiner","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2026.03.009_bib0013","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/gast.2001.25481","article-title":"Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis","volume":"121","author":"Lisman","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2026.03.009_bib0014","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/jhep.2003.50277","article-title":"Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis","volume":"38","author":"Colucci","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2026.03.009_bib0015","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2023.01.010","article-title":"Haemostasis in cirrhosis: understanding destabilising factors during acute decompensation","volume":"78","author":"Zanetto","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2026.03.009_bib0016","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/j.cgh.2023.04.016","article-title":"Bleeding and thrombotic complications in patients with cirrhosis: a state-of-the-art appraisal","volume":"21","author":"Rautou","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2026.03.009_bib0017","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.thromres.2022.05.004","article-title":"Incidence and prevalence of venous thromboembolism in chronic liver disease: a systematic review and meta-analysis","volume":"215","author":"Subhani","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.dld.2026.03.009_bib0018","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/j.1572-0241.2006.00588.x","article-title":"Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism","volume":"101","author":"Northup","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2026.03.009_bib0019","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1002\/hep.32019","article-title":"Risk and outcome of venous and arterial thrombosis in patients with cirrhosis: a Danish nation-wide cohort study","volume":"74","author":"Jepsen","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2026.03.009_bib0020","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/liv.15325","article-title":"Incidence and outcomes of thromboembolic and bleeding events in patients with liver cirrhosis in the USA","volume":"43","author":"Huang","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2026.03.009_bib0021","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/ajh.27106","article-title":"Long-term risk of venous thromboembolism among patients with gastrointestinal non-neoplastic and neoplastic diseases: a prospective cohort study of 484\u2009211 individuals","volume":"99","author":"Yuan","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.dld.2026.03.009_bib0022","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.jtha.2024.05.023","article-title":"Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH","volume":"22","author":"Carlin","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.dld.2026.03.009_bib0023","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/jth.12805","article-title":"Risks of venous thromboembolism in patients with liver cirrhosis: a nationwide cohort study in Taiwan","volume":"13","author":"Ng","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.dld.2026.03.009_bib0024","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1111\/jth.14255","article-title":"Venous thromboembolism in patients with liver diseases","volume":"16","author":"Barba","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.dld.2026.03.009_bib0025","article-title":"Predictors of deep venous thrombosis in hospitalized patients with liver cirrhosis in the US","volume":"14","author":"Abou Yassine","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.dld.2026.03.009_bib0026","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s11739-022-02928-8","article-title":"Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients","volume":"17","author":"Faccia","year":"2022","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.dld.2026.03.009_bib0027","doi-asserted-by":"crossref","first-page":"67","DOI":"10.14740\/gr1493","article-title":"The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis among hospitalized cirrhotic patients","volume":"15","author":"Alsheikh","year":"2022","journal-title":"Gastroenterology Res"},{"key":"10.1016\/j.dld.2026.03.009_bib0028","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1007\/s10620-024-08440-7","article-title":"Impact of cirrhosis etiology on the risk for venous thromboembolism","volume":"69","author":"Pemmasani","year":"2024","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2026.03.009_bib0029","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/liv.15609","article-title":"Safety and efficacy of venous thromboembolism prophylaxis in patients with cirrhosis: a systematic review and meta-analysis","volume":"43","author":"Pasta","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2026.03.009_bib0030","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/MEG.0000000000002564","article-title":"Outcome of pharmacological thromboprophylaxis in hospitalized patients with cirrhosis - a systematic review and meta-analysis","volume":"35","author":"Giri","year":"2023","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2026.03.009_bib0031","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1177\/00031348231177933","article-title":"Trauma patients with cirrhosis have a similar risk of unplanned operation and decreased associated risk of mortality with venous thromboembolism chemoprophylaxis","volume":"89","author":"Alvarez","year":"2023","journal-title":"Am Surg"},{"key":"10.1016\/j.dld.2026.03.009_bib0032","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/jth.15829","article-title":"Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: guidance from the SSC of the ISTH","volume":"20","author":"Roberts","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.dld.2026.03.009_bib0033","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jhep.2021.09.003","article-title":"EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis","volume":"76","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2026.03.009_bib0034","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/MEG.0000000000001315","article-title":"W. Epidemiology of atrial fibrillation in patients with cirrhosis and clinical significance: a meta-analysis","volume":"31","author":"Chokesuwattanaskul","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2026.03.009_bib0035","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008703","article-title":"Liver disease as a predictor of new-onset atrial fibrillation","volume":"7","author":"Huang","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.dld.2026.03.009_bib0036","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12668","article-title":"Atrial fibrillation, liver cirrhosis, thrombosis, and bleeding: a Danish population-based cohort study","volume":"6","author":"B Riahi","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.dld.2026.03.009_bib0037","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1747493019897870","article-title":"Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge","volume":"16","author":"Lippi","year":"2021","journal-title":"Int J Stroke"},{"key":"10.1016\/j.dld.2026.03.009_bib0038","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.dld.2018.12.001","article-title":"Efficacy and safety of anticoagulation for atrial fibrillation in patients with cirrhosis: a systematic review and meta-analysis","volume":"51","author":"Chokesuwattanaskul","year":"2019","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2026.03.009_bib0039","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.31264","article-title":"Mortality and hepatic decompensation in patients with cirrhosis and atrial fibrillation treated with anticoagulation","volume":"73","author":"Serper","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2026.03.009_bib0040","doi-asserted-by":"crossref","DOI":"10.1177\/10742484241256271","article-title":"Assessing safety of anticoagulation for atrial fibrillation in patients with cirrhosis: a real-world outcomes study","volume":"29","author":"Song","year":"2024","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.dld.2026.03.009_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2025.102534","article-title":"Efficacy and safety of direct oral anticoagulants compared to vitamin K antagonists for atrial fibrillation in patients with liver cirrhosis: an update systematic review and meta-analysis","volume":"15","author":"Miranda","year":"2025","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.dld.2026.03.009_bib0042","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejim.2022.05.032","article-title":"Epidemiology of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis","volume":"104","author":"Pan","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.dld.2026.03.009_bib0043","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1148\/radiol.12112236","article-title":"Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis","volume":"265","author":"Luca","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.dld.2026.03.009_bib0044","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.27546","article-title":"Causes and consequences of portal vein thrombosis in 1243 patients with cirrhosis: results of a longitudinal study","volume":"61","author":"Nery","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2026.03.009_bib0045","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jhep.2021.04.029","article-title":"Current knowledge and management of portal vein thrombosis in cirrhosis","volume":"75","author":"Senzolo","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2026.03.009_bib0046","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.jhep.2021.07.020","article-title":"Predicting portal thrombosis in cirrhosis: a prospective study of clinical, ultrasonographic and hemostatic factors","volume":"75","author":"Turon","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2026.03.009_bib0047","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/j.cgh.2020.02.037","article-title":"Prevalence and clinical significance of portal vein thrombosis in patients with cirrhosis and acute decompensation","volume":"18","author":"Zhang","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2026.03.009_bib0048","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12916-018-1069-8","article-title":"Transient portal vein thrombosis in liver cirrhosis","volume":"16","author":"Qi","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/j.dld.2026.03.009_bib0049","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1111\/jgh.16263","article-title":"Natural history of portal vein thrombosis in cirrhosis: a systematic review with meta-analysis","volume":"38","author":"Giri","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2026.03.009_bib0050","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/HEP.0000000000000538","article-title":"Role of nonneoplastic PVT in the natural history of patients with cirrhosis and first diagnosis of HCC","volume":"79","author":"Senzolo","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2026.03.009_bib0051","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/jcu.23523","article-title":"Assessment of portal system hemodynamics for the prediction of portal vein thrombosis in cirrhosis-a systematic review and meta-analysis","volume":"51","author":"Giri","year":"2023","journal-title":"J Clin Ultrasound"},{"key":"10.1016\/j.dld.2026.03.009_bib0052","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12876-024-03399-1","article-title":"Effect of factor VIII and FVIII\/PC ratio on portal vein thrombosis in liver cirrhosis: a systematic review and meta\u2011analysis","volume":"24","author":"Wu","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.dld.2026.03.009_bib0053","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/rth2.12253","article-title":"Inherited thrombophilia and portal vein thrombosis in cirrhosis: a systematic review and meta-analysis","volume":"3","author":"Ma","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.dld.2026.03.009_bib0054","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1097\/MEG.0000000000001982","article-title":"Systemic inflammation as a risk factor for portal vein thrombosis in cirrhosis: a prospective longitudinal study","volume":"33","author":"Nery","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2026.03.009_bib0055","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s12072-019-09951-6","article-title":"Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis","volume":"13","author":"Xu","year":"2019","journal-title":"Hepatol Int"},{"key":"10.1016\/j.dld.2026.03.009_bib0056","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000025439","article-title":"Effect of portal vein thrombosis on the prognosis of patients with cirrhosis without a liver transplant: a systematic review and meta-analysis","volume":"100","author":"Xian","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.dld.2026.03.009_bib0057","first-page":"1238","article-title":"Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension","volume":"21","author":"Wanless","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2026.03.009_bib0058","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cgh.2014.10.010","article-title":"Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis","volume":"13","author":"Berry","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2026.03.009_bib0059","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14520","article-title":"Meta-analysis and systematic review: prevalence, graft failure, mortality, and post-operative thrombosis in liver transplant recipients with pre-operative portal vein thrombosis","volume":"36","author":"Yeo","year":"2022","journal-title":"Clin Transplant"},{"key":"10.1016\/j.dld.2026.03.009_bib0060","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/00365521.2025.2450043","article-title":"Efficacy and safety of anticoagulation in asymptomatic cirrhotic patients with portal vein thrombosis: a systematic review and meta-analysis","volume":"60","author":"Wu","year":"2025","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2026.03.009_bib0061","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jceh.2022.12.016","article-title":"Anticoagulation for the treatment of portal vein thrombosis in cirrhosis: a systematic review and meta-analysis of comparative studies","volume":"13","author":"Yao","year":"2023","journal-title":"J Clin Exp Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2026.03.009_bib0062","doi-asserted-by":"crossref","first-page":"E107","DOI":"10.1111\/hepr.12934","article-title":"Antithrombin III for portal vein thrombosis in patients with liver disease: a randomized, double-blind, controlled trial","volume":"48","author":"Hidaka","year":"2018","journal-title":"Hepatol Res"},{"key":"10.1016\/j.dld.2026.03.009_bib0063","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000228","article-title":"Efficacy and safety of nadroparin calcium-warfarin sequential anticoagulation in portal vein thrombosis in cirrhotic patients: a randomized controlled trial","volume":"11","author":"Zhou","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.dld.2026.03.009_bib0064","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2023.02.023","article-title":"Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: the importal competing-risk meta-analysis","volume":"79","author":"Guerrero","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2026.03.009_bib0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.dld.2021.07.039","article-title":"Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: a systematic review and meta-analysis","volume":"54","author":"Koh","year":"2022","journal-title":"Dig Liver Dis"},{"issue":"13","key":"10.1016\/j.dld.2026.03.009_bib0066","first-page":"968","article-title":"Transjugular intrahepatic portosystemic shunt for the prevention of rebleeding in patients with cirrhosis and portal vein thrombosis: systematic review and meta-analysis","volume":"16","author":"Guo","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.dld.2026.03.009_bib0067","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.gassur.2023.12.031","article-title":"Safety and efficacy of transjugular intrahepatic portosystemic shunts vs endoscopic band ligation plus propranolol in patients with cirrhosis with portal vein thrombosis: a systematic review and meta-analysis","volume":"28","author":"Berengy","year":"2024","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.dld.2026.03.009_bib0068","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.14309\/ajg.0000000000001194","article-title":"Anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis: a prospective observational study","volume":"116","author":"Lv","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2026.03.009_bib0069","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1053\/j.gastro.2024.10.038","article-title":"AGA clinical practice update on management of portal vein thrombosis in patients with cirrhosis: expert review","volume":"168","author":"Davis","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2026.03.009_bib0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jhep.2025.01.029","article-title":"European Association for the Study of the Liver. EASL Clinical practice guidelines on TIPS","volume":"83","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2026.03.009_bib0071","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis","volume":"143","author":"Villa","year":"2012","journal-title":"Gastroenterology"},{"issue":"S2","key":"10.1016\/j.dld.2026.03.009_bib0072","article-title":"Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebo controlled trial (Abstract)","volume":"78","author":"Puente Sanchez","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2026.03.009_bib0073","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12072-024-10734-x","article-title":"Treatment of portal vein thrombosis in cirrhosis is associated with no survival advantage: A retrospective controlled study","volume":"19","author":"Cheloff","year":"2025","journal-title":"Hepatol Int"},{"key":"10.1016\/j.dld.2026.03.009_bib0074","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.cgh.2017.10.016","article-title":"Harmful and beneficial effects of anticoagulants in patients with cirrhosis and portal vein thrombosis","volume":"16","author":"La Mura","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.dld.2026.03.009_bib0075","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41424-018-0043-2","article-title":"Long-term outcome of splanchnic vein thrombosis in cirrhosis","volume":"15","author":"Senzolo","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.dld.2026.03.009_bib0076","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhepr.2019.02.006","article-title":"Anticoagulation in the cirrhotic patient","volume":"1","author":"Turco","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.dld.2026.03.009_bib0077","article-title":"Direct oral anticoagulants in cirrhosis: rationale and current evidence","volume":"6","author":"Pereira Portela","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.dld.2026.03.009_bib0078","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","article-title":"European association for the study of the liver. EASL clinical practice guidelines: vascular diseases of the liver","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2026.03.009_bib0079","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American association for the study of liver diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2026.03.009_bib0080","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865826003221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865826003221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:23:18Z","timestamp":1781652198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865826003221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":80,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1590865826003221"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2026.03.009","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombosis and anticoagulation in patients with Cirrhosis. An overview","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2026.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}